Abstract

In a previous study, we identified TRIB1, a serine-threonine kinase-like molecule, as a biomarker of chronic antibody-mediated rejection of human kidneys when measured in peripheral blood mononuclear cells. Here, we focused our analysis on a specific subset of peripheral blood mononuclear cells that play a dominant role in regulating immune responses in health and disease, so-called CD4(+)CD25(+)Foxp3(+) regulatory T cells (Tregs). We isolated both human and murine Treg and non-Treg counterparts and analyzed TRIB1 and Foxp3 mRNA expression by quantitative PCR on the freshly isolated cells or following 24 h of activation. Physical interaction between the human TRIB1 and Foxp3 proteins was analyzed in live cell lines by protein complementation assay using both flow cytometry and microscopy and confirmed in primary freshly isolated human CD4(+)CD25(hi)CD127(-) Tregs by co-immunoprecipitation. Both TRIB1 and Foxp3 were expressed at significantly higher levels in Tregs than in their CD4(+)CD25(-) counterparts (p < 0.001). Moreover, TRIB1 and Foxp3 mRNA levels correlated tightly in Tregs (Spearman r = 1.0; p < 0.001, n = 7), but not in CD4(+)CD25(-) T cells. The protein complementation assay revealed a direct physical interaction between TRIB1 and Foxp3 in live cells. This interaction was impaired upon deletion of the TRIB1 N-terminal but not the C-terminal domain, suggesting an interaction in the nucleus. This direct interaction within the nucleus was confirmed in primary human Tregs by co-immunoprecipitation. These data show a direct relationship between TRIB1 and Foxp3 in terms of their expression and physical interaction and highlight Tribbles-1 as a novel binding partner of Foxp3 in Tregs.

Highlights

  • TRIB1, a serine-threonine kinase-like molecule, is a biomarker of chronic antibody-mediated rejection

  • We found TRIB1 mRNA, similar to of Foxp3, to be expressed at significantly higher levels in human CD4ϩ CD25ϩCD127Ϫ Tregs compared with their CD4ϩCD25Ϫ T cells counterparts (Fig. 2A) (p Ͻ 0.001 for TRIB1 and Foxp3)

  • TRIB1 and Foxp3 mRNA expression in human regulatory T cells (r ϭ 1.0; p ϭ 0,0004; Fig. 2A) but not in CD4ϩCD25Ϫ T cells, suggesting a strong link between the regulation of TRIB1 and Foxp3 expression in the Tregs. These results were confirmed in C57Bl6 mice where, again, an increase in TRIB1 and Foxp3 levels was observed in CD4ϩCD25ϩ Tregs compared with CD4ϩCD25Ϫ cells (p Ͻ 0.05 for TRIB1 and p Ͻ 0.01 for Foxp3) (Figs. 1 and 2B)

Read more

Summary

Background

TRIB1, a serine-threonine kinase-like molecule, is a biomarker of chronic antibody-mediated rejection. We identified TRIB1, a serine-threonine kinase-like molecule, as a biomarker of chronic antibody-mediated rejection of human kidneys when measured in peripheral blood mononuclear cells. We focused our analysis on a specific subset of peripheral blood mononuclear cells that play a dominant role in regulating immune responses in health and disease, so-called CD4؉CD25؉Foxp3؉ regulatory T cells (Tregs) We isolated both human and murine Treg and nonTreg counterparts and analyzed TRIB1 and Foxp mRNA expression by quantitative PCR on the freshly isolated cells or following 24 h of activation. Physical interaction between the human TRIB1 and Foxp proteins was analyzed in live cell lines by protein complementation assay using both flow cytometry and microscopy and confirmed in primary freshly isolated human CD4؉CD25hiCD127؊ Tregs by co-immunoprecipitation. We explore TRIB1 expression in Tregs and subsequently demonstrate a physical link between TRIB1 and the key Treg marker Foxp

EXPERIMENTAL PROCEDURES
The abbreviations used are
RESULTS
DISCUSSION
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.